Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
denagard vet 450 mg/g rakeet
elanco gmbh - tiamulini hydrogenofumaras - rakeet - 450 mg/g - tiamuliini
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
denagard vet 20 mg/g jauhe
elanco gmbh - tiamulini hydrogenofumaras - jauhe - 20 mg/g - tiamuliini
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
dynamutilin vet 450 mg/g jauhe
novo nordisk a/s - tiamulini hydrogenofumaras - jauhe - 450 mg/g - tiamuliini
Phần Lan -
Tiếng Phần Lan -
Fimea (Suomen lääkevirasto)
caremast vet 600 mg intramammaarisuspensio
vetcare oy - procaine benzylpenicillin monohydrate - intramammaarisuspensio - 600 mg - prokaiinipenisilliini
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Liên Minh Châu Âu -
Tiếng Phần Lan -
EMA (European Medicines Agency)
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).